Hosted on MSN1mon
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
That drug is in mid-stage testing. J&J, based in New Brunswick, New Jersey, says it will pay for the deal, valued at about $14.6 billion, with a combination of cash and debt. The companies expect ...
Nature5y
Johnson & Johnson acquires Centocor
In mid-July, Johnson & Johnson (J&J; New Brunswick, NJ) announced that it will use $4.9 million in stock to acquire one of the biopharmaceutical sector's longest lived companies, Centocor (Malvern ...
Fortune1y
Johnson & Johnson
Headquartered in New Brunswick, N.J., the company operates over 250 subsidiary companies in more than 60 countries. Best known for brands like Band-Aid, Tylenol, and Johnson's baby products ...